Krystal Biotech buy Stifel Nicolaus
Start price
16.04.24
/
50%
€162.85
Target price
16.04.25
€191.76
Performance (%)
-10.87%
Price
25.04.24
€145.15
Summary
This prediction is currently active. The prediction for Krystal Biotech disappoints with a performance of -10.87%. This prediction currently runs until 16.04.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Krystal Biotech | -2.420% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by Stifel_Nicolaus for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
Ratings data for KRYS provided by MarketBeat